Combination of brimonidine and timolol for topical ophthalmic use

CAFC
  • US 9,907,802 B1
  • Filed: 11/02/2017
  • Issued: 03/06/2018
  • Est. Priority Date: 04/19/2002
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating a patient with glaucoma or ocular hypertension comprising topically administering twice daily to an affected eye of the patient a single composition comprising 0.2% w/v brimonidine tartrate and 0.68% w/v timolol maleate as the sole active ingredients, wherein the method is as effective at reducing intraocular pressure as the administration of 0.2% w/v brimonidine tartrate monotherapy three times per day.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×